EcoDrugPlus

Estrogen Receptor Beta-Like

Ensembl ID : ENSPLAG00000001942
Gene Symbol: LOC106939661
3 Cross references
198 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSPLAG00000004793
Gene Symbol: LOC106950473
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPLAG00000000356
Gene Symbol: XPO1
3 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPLAG00000018279
Gene Symbol: XPO1
3 Cross references
213 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSPLAG00000019056
Gene Symbol: FDPS
3 Cross references
265 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSPLAG00000000801
Gene Symbol: LOC106938027
3 Cross references
265 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSPLAG00000020047
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSPLAG00000007635
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSPLAG00000013010
Gene Symbol: FGFR1
1 Cross references
203 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSPLAG00000013089
Gene Symbol: LOC106945036
4 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2-Like

Ensembl ID : ENSPLAG00000007652
Gene Symbol: LOC106957871
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSPLAG00000005710
Gene Symbol: FGFR3
3 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).